ArticleNaunyn-Schmiedeberg's archives of pharmacology2017

Bufalin attenuates cancer-induced pain and bone destruction in a model of bone cancer.

Dongxing Ji et al.PubMed ↗Publisher ↗

No numbers read from the abstract.